Molina Healthcare Inc

Molina Healthcare shares fell 9.4% after hours despite an earnings beat, as first-half adjusted EPS of $3.86 covers 73.5% of the 2026 floor, leaving a $1.39 gap to the full-year floor.

UnitedHealth Group stock rose slightly as investors assessed a modest proposed Medicare Advantage payment increase for 2027. The healthcare giant continues to navigate pressure following a significant revenue warning earlier this year.

UnitedHealth shares gained 3% Friday to $276.65, stabilizing after a turbulent period for managed-care stocks. Investors now await earnings from CVS Health and Humana next week for critical updates on Medicare Advantage trends.

Hims & Hers discontinues its $49 compounded semaglutide offering following FDA enforcement signals, sending shares down 16%. Molina Healthcare forecasts 2026 profit far below expectations, triggering a 28% stock drop.

UnitedHealth shares rose 3% to $276.65 Friday, recovering after Molina Healthcare's weak 2026 forecast pressured the sector. Investors now await Humana's results and a key Medicare Advantage rate decision.

Molina Healthcare plummeted 25.5% after slashing its 2026 profit forecast and announcing a Medicare Part D exit, while the Health Care Select Sector SPDR Fund (XLV) rose 1.8%. Regulatory warnings on compounded obesity drugs added pressure to the sector.